Five hundred forty-two specimens of 150 children enrolled in the AML-Berlin-Frankfurt-Muenster (BFM) 98 study were analyzed by four-color immunophenotyping at up to four predefined time points during ...

Correction to "Clinical application of flow cytometry in patients with unexplained cytopenia and suspected myelodysplastic syndrome: A report of the European LeukemiaNet International MDS-Flow ...

A cross-continental study suggests that in the treatment of acute myeloid leukemia, age affects survival, independent of ...

One huge reason why the world of medicine hasn't yet found "the cure" for hard-to-treat malignancies like acute myeloid ...

In this three-part webinar series, we invite you to explore the benefits of a standardized workflow in leukemia and lymphoma analysis. Join this showcase of Beckman Coulter’s new DxFLEX flow cytometer ...

Cullinan Therapeutics (CGEM) announced new clinical data from its Phase 1 study of CLN-049, a novel, investigational FLT3xCD3 bispecific T cell engager, in patients with relapsed/refractory acute ...

Characterizing clonal evolution in blood cancers like acute myeloid leukemia (AML) is critical for understanding their mutational histories and how cell populations change during disease development.

AI is being leveraged in hematology for image analysis and biomarker prediction, with slow uptake of regulator-approved devices but significant "shadow use" of nonapproved applications. AI agents may ...